Published in Vaccine Weekly, June 27th, 2007
"The global burden of severe group A streptococcal disease is concentrated largely in developing countries and Indigenous populations such...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.